Finance

Beta
Lists
600594:SHA
GuiZhou YiBai Pharmaceutical Co., Ltd.
CN¥3.29
0.00%
(0.00) 1D
Jun 15, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600594...
Open
CN¥3.32
High
CN¥3.37
Low
CN¥3.25
Mkt. cap
2.61B
Avg. vol.
26.04M
Volume
15.06M
52-wk high
CN¥5.27
52-wk low
CN¥3.18
EPS
-CN¥0.44
Shares outstanding
791.93M
No. of employees
5K
Open
CN¥3.32
High
CN¥3.37
Low
CN¥3.25
Mkt. cap
2.61B
Avg. vol.
26.04M
Volume
15.06M
52-wk high
CN¥5.27
52-wk low
CN¥3.18
EPS
-CN¥0.44
Shares outstanding
791.93M
No. of employees
5K
News stories
From sources across the web
About GuiZhou YiBai Pharmaceutical Co., Ltd.
CEO-
Employees4.83K
FoundedJun 12, 1995
Headquarters-
SectorPharmaceutical industry
Websitegzcci.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
491.64M
453.58M
416.22M
358.84M
Cost of goods sold
208.66M
165.60M
205.61M
150.99M
Cost of revenue
208.66M
165.60M
205.61M
150.99M
Research and development expenses
16.50M
25.31M
21.85M
13.47M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
278.69M
276.16M
283.81M
196.25M
Operating expense
305.02M
292.28M
328.94M
213.94M
Total operating expenses
513.68M
457.88M
534.55M
364.93M
Operating income
-22.04M
-4.30M
-118.33M
-6.09M
Other non operating income
210.08K
-1.51M
-122.19K
-228.77K
EBT including unusual items
-13.85M
-69.17M
-218.73M
-20.88M
EBT excluding unusual items
-23.29M
-11.96M
-123.43M
-11.52M
Income tax expense
-2.92M
-898.39K
25.98M
8.09M
Effective tax rate
21.06%
1.30%
-11.88%
-38.74%
Other operating expenses
8.49M
-9.81M
23.29M
4.27M
Net income
-10.52M
-66.66M
-243.00M
-29.52M
Net profit margin
-2.14%
-14.70%
-58.38%
-8.23%
Earnings per share
-
-
-
-
Interest and investment income
723.43K
1.13M
979.10K
485.26K
Interest expense
-2.18M
-7.28M
-5.96M
-5.69M
Net interest expenses
-1.46M
-6.15M
-4.98M
-5.21M
Depreciation and amortization charges
-
-
-
-
EBITDA
19.41M
41.68M
-77.35M
34.89M
Gain or loss from assets sale
-17.43K
17.43K
27.21M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more